Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001209191-21-052512

Chief Financial Officer bought 3,000 shares at $3.92 ($11,760)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Freve Jonathan Chief Financial Officer 2021-08-18 Purchase +3,000 $3.92 $11,760 5,000 D
Open-market purchases · 3,000 sh · avg $3.92 · $11,760
Loading xslF345X03/doc4.xml…